Picard Medical is trading at $6.49, down 6.36% in pre-market, with no clear company-specific explanation identified for the October 6 decline. - Shares had gained 19.90% on October 5 and 33.80% on October 2 before the pullback. - Recent coverage also found no identified catalyst for the rally; profit-taking is a possible but unconfirmed explanation. - Major indices were modestly higher in the supplied market context, offering no clear broad-market explanation.